What is the age indication for Pazeo?

Pazeo (olopatadine hydrochloride) is an antihistamine eye drop indicated for the treatment of allergic conjunctivitis. The correct age indication for Pazeo is from 2 years and up. This information is important as it guides healthcare professionals and caregivers in determining when it is appropriate to administer this medication to children.

In pediatric use, it's crucial to have well-defined age indications to ensure the safety and efficacy of the treatment. The approval for use starting at 2 years ensures that the medication is suitable for younger children who may experience allergic symptoms but may not be safe or effective for those who are younger.

The other age options would not align with the product labeling and clinical trial findings that support the use of Pazeo starting at 2 years of age. It underscores the regulatory standards in place to protect younger patients from potentially inappropriate uses of medications.